Stay updated on Rilonacept Long-Term Safety Efficacy in Gout Flares Clinical Trial
Sign up to get notified when there's something new on the Rilonacept Long-Term Safety Efficacy in Gout Flares Clinical Trial page.

Latest updates to the Rilonacept Long-Term Safety Efficacy in Gout Flares Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.1 instead of v3.8.0. The study record content remains unchanged.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe clinical-trial record for the terminated UPSURGE study of rilonacept for preventing gout flares is now displayed, with its study design, participant criteria, results measures, and other record details.SummaryDifference65%

- Check22 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0. The study record remains unavailable behind a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check36 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check43 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Rilonacept Long-Term Safety Efficacy in Gout Flares Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rilonacept Long-Term Safety Efficacy in Gout Flares Clinical Trial page.